KLOW and GLP-1 medications act through different receptor systems while there is no direct synergy, KLOW can support tissue healing from training and reduce inflammation during GLP-1-induced rapid weight loss
Avoid freeze-thaw cycles
When NAD+ levels are adequate, SIRT1 activity increases, promoting DNA repair, reducing inflammation, and enhancing stress resistance
In animal studies, AOD-9604 reduced body weight gain by over 50% in obese mice during a 19-day treatment period, and significantly increased fat oxidation all without affecting insulin sensitivity or glucose regulation.[1,3] A randomized controlled trial in humans found that participants taking 1 mg of AOD-9604 daily lost an average of 2.8 kg (~6 lbs) over 23 weeks, compared to 0.8 kg (~1.7 lbs) in the placebo group
This page also connects the product to related peptide guides, supplier comparisons, discount-code resources, and calculator tools so visitors can continue researching the compound, compare alternatives, and understand sourcing context without relying on a single vendor claim